Lv4
660 积分 2025-05-22 加入
Tirzepatide Once Weekly for the Treatment of Obesity
1个月前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
4个月前
已完结
A review of survodutide: a new dual acting agonist
4个月前
已完结
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
5个月前
已完结
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
5个月前
已完结
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
5个月前
已完结
American Association of Clinical Endocrinologists and American College of Endocrinology Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action
5个月前
已完结
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
5个月前
已完结
Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials
7个月前
已完结
[求助补充材料] New England Journal of Medicine (NEJM) Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis - Protocol (nejmoa2413258_protocol.pdf)
11个月前
已完结
皖公网安备34019202002308
